Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2019-09-26 to 2026-11-19
Current total value of award: $26877810
Description: ANALGESIC KETAMINE-CLINICAL TRIAL